News Highlights

Check this page for recent news from Appili Therapeutics.

Members of the media can contact us here, or for general inquiries, contact us here.

October 14, 2021
Appili Therapeutics Announces Closing of Public Offering of $7,000,220
October 7, 2021
Appili Therapeutics Announces Pricing of Overnight Marketed Equity Offering
October 6, 2021
Appili Therapeutics Announces Overnight Marketed Equity Offering
September 29, 2021
Appili Therapeutics and AiPharma Announce Strategic Alliance and Equity Transaction
September 23, 2021
Appili Therapeutics Announces Last Patient Enrolled in Phase 3 Trial of Oral Avigan®/Reeqonus™ for the Treatment of Mild-to-Moderate COVID-19